MedPath
NMPA Approval

Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets

国药准字HJ20180043

February 14, 2023

H20180043

Drug Information

艾考恩丙替片

捷扶康

片剂

每片含150mg艾维雷韦,150mg考比司他,200mg恩曲他滨和10mg丙酚替诺福韦

化学药品

February 14, 2023

February 13, 2028

Company Information

Applicant Company

Carrigtohill, County Cork, T45 DP77, Ireland

Manufacturing Company

Patheon Inc

2100 Syntex Court, Mississauga, L5N 7K9 Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

艾考恩丙替片 - NMPA 批准文号 | MedPath